Analyst
RBC
Equibles does not estimate personal net worth.
Ryan Halstead is recorded as Analyst at RBC. Ryan Halstead has spoken on 10 earnings calls and 1 other investor event across 7 companies, most recently for Medpace Holdings, Inc. on October 22, 2026. Those appearances were for Medpace Holdings, Inc. (MEDP), Phreesia, Inc. (PHR), Healthequity, Inc. (HQY), Charles River Laboratories International, Inc. (CRL), Sotera Health Co (SHC) and 2 other companies. The companies whose calls Ryan Halstead spoke on are classified in the Healthcare sector.
“Maybe going back to the new awards and, you know, good to see that they're growing healthy.”
“Maybe a question regarding your payment solutions business. You know, any color on macro trends into patient volumes, you know, from your perspective of facilitating 180 million visits?”
“Maybe just a two-parter on the strong new sales growth. Just any commentary on the competitive landscape, you know, how your win rate has been trending or RFP trending?”
“My first question is on Nelson Labs. just was interested in any update on the validation testing pipeline and how you see that progressing in the back half of the year and how we should think about kind of the cadence of that impacting versus the guide.”
“My question is just on the guidance raise, if you could just offer some more color on the incremental visibility you have into the bookings that you now expect to convert in the second half.”
RBC
Analyst
Transcript header (unverified)
Diagnostics & Research · Healthcare
PHR
Health Information Services · Healthcare
Health Information Services · Healthcare
Diagnostics & Research · Healthcare
SHC
Diagnostics & Research · Healthcare
ICLR
Diagnostics & Research · Healthcare
CERT
Health Information Services · Healthcare
